Growth Metrics

Vericel (VCEL) EBITDA Margin Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 3,609.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1,536.00
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -957.00
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 8,807.00
10 Vericel 1.69 Bn 1.55 Bn 49.27 Mn 1,254.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1,254.00
Dec 31, 2025 -39.00
Sep 30, 2025 937.00
Jun 30, 2025 824.00
Mar 31, 2025 -1,367.00
Dec 31, 2024 493.00
Sep 30, 2024 684.00
Jun 30, 2024 153.00
Mar 31, 2024 928.00
Dec 31, 2023 804.00
Sep 30, 2023 651.00
Jun 30, 2023 1,153.00
Mar 31, 2023 35.00
Dec 31, 2022 285.00
Sep 30, 2022 -323.00
Jun 30, 2022 -1,508.00
Mar 31, 2022 -1,046.00
Dec 31, 2021 -1,847.00
Sep 30, 2021 -2,528.00
Jun 30, 2021 3,232.00
Mar 31, 2021 920.00
Dec 31, 2020 379.00
Sep 30, 2020 75.00
Jun 30, 2020 3,548.00
Mar 31, 2020 -363.00
Dec 31, 2019 425.00
Sep 30, 2019 1,610.00
Jun 30, 2019 -5,491.00
Mar 31, 2019 858.00
Dec 31, 2018 1,403.00
Sep 30, 2018 2,233.00
Jun 30, 2018 -746.00
Mar 31, 2018 7,882.00
Dec 31, 2017 0.00
Sep 30, 2017 3,011.00
Jun 30, 2017 2,400.00
Mar 31, 2017 -8,868.00
Dec 31, 2016 3,725.00
Sep 30, 2016 -1,525.00
Jun 30, 2016 -2,220.00
Mar 31, 2016 572.00
Dec 31, 2015 -1,620.00
Sep 30, 2015 3,994.00
Jun 30, 2015 17,562.00
Dec 31, 2014 6.15 Mn
Jun 30, 2014 17.43 Mn
Dec 31, 2013 -2.15 Mn
Mar 31, 2013 33.83 Mn
Mar 31, 2012 -35.83 Mn